Recruiting at 1 site Phase 3 Migraine

Migraine study: Magnesium

Official title Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

ClinicalTrials.gov ID: NCT06904287

What this study is testing

What is Magnesium?

This is an investigational intravenous medicine being studied to see if it helps reduce migraine pain when used with prochlorperazine. Magnesium is designed to help relax blood vessels and may reduce nerve activity in the brain.

Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
The study aims to see whether adding magnesium to the medication prochlorperazine can lessen migraine pain.
Who it's for
Adults who experience migraines.
What's involved
Participants will receive magnesium along with prochlorperazine and may have visits or tests as part of the study.
Time commitment
The study will last for a specified period with scheduled visits, but exact duration and number of visits are not detailed in the source.
  • Phase 3: a large, late-stage study
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age ≥ 18 years or older
  • Able to provide informed consent
  • English speaking
  • Primary diagnosis of migraine. Patient with a previous diagnosis of migraine, who experience headaches with typical migraine features (e.g at least...

You likely can't join if

  • Pregnancy defined as a positive urine HCG
  • Allergy or sensitivity to study drug
  • Stated history of renal insufficiency
  • Documented history of myasthenia gravis
  • Consumption of study drug within 48 hours prior to enrollment
  • Previously enrolled in this trial during a different patient encounter

The study team makes the final eligibility decision.

Where it is enrolling

  • Oak Lawn, Illinois, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Oak Lawn, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.